Systematic Method Development of UPC2 Conditions Using Opioid Drugs

This Waters application note uses a panel of natural and synthetic opioid drugs to demonstrate the use of a systematic screening strategy for UPC2 method development.

Written byWaters Corporation
| 1 min read

The simultaneous evaluation of multiple column chemistries and several different mobile-phase additives allows rapid determination of preferred starting conditions for further optimization. This enabled easy and rapid optimization of conditions to achieve a method capable of analyzing 19 different opioid drugs in less than 2 minutes, with acceptable retention and peak shape for all compounds. In addition, this method further highlights the potential utility of UPC2 for the analysis of a wide variety of compound classes.

Get the full application note here.

 

Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Loading Next Article...
Loading Next Article...
Current Magazine Issue Background Image

CURRENT ISSUE - April 2026

When Lab Innovation Meets Sustainability

Why Performance, Cost, and Environmental Impact Now Compete in Procurement

Lab Manager April 2026 Cover Image